Related Experiment Videos
Ligand-based identification of environmental estrogens
C L Waller1, T I Oprea, K Chae
1Experimental Toxicology Divisions, United States Environmental Protection Agency, Research Triangle Park, North Carolina 27711, USA. waller@thor.herl.epa.gov
Chemical Research in Toxicology
|December 1, 1996
Summary
This study used Comparative Molecular Field Analysis (CoMFA), a 3D-QSAR method, to analyze estrogen receptor (ER) binding affinities. The model accurately predicts binding, aiding in identifying potential endocrine disruptors.
Area of Science:
- Pharmacology
- Toxicology
- Computational Chemistry
Background:
- Estrogen receptor (ER) binding is crucial for understanding the activity of various chemicals.
- Structurally diverse compounds interact with the ER, necessitating methods to predict their binding affinities.
- Identifying endocrine disruptors requires robust predictive models for chemical interactions with hormone receptors.
Purpose of the Study:
- To develop and validate a 3D-QSAR model using CoMFA for predicting ER binding affinities.
- To assess the necessity and sufficiency of steric and electrostatic properties in ER ligand binding.
- To evaluate the model's utility in prioritizing compounds for endocrine disruptor screening.
Main Methods:
- Comparative Molecular Field Analysis (CoMFA) was employed as a 3D-QSAR technique.
- A series of structurally diverse natural, synthetic, and environmental chemicals were analyzed.
- Statistical robustness and internal consistency of the CoMFA model were rigorously evaluated.
Main Results:
- The CoMFA/3D-QSAR model demonstrated statistical robustness and internal consistency.
- Steric and electrostatic properties were identified as necessary and sufficient determinants of ER binding affinity.
- The model accurately predicted the ER binding affinity of an external test set of molecules.
Conclusions:
- Structure-based 3D-QSAR models, like the developed CoMFA model, can effectively predict ER binding.
- These models can aid in the identification and prioritization of potential endocrine disruptors.
- Further toxicological applications are contingent on the availability of comprehensive biological data for relevant biomarkers.